Navigation Links
PFC Pharma Joins DATATRAK's CRO Connect Program
Date:11/30/2009

CLEVELAND, Nov. 30 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that PFC Pharma Focus AG (PFC) has joined its CRO Connect Program. PFC will now have the ability to contract for DATATRAK's CRO partner training and offer its clients the DATATRAK eClinical(TM) product suite. In addition, PFC will also have access to Partner preferred pricing, business development and joint marketing support. PFC is a premium Contract Research Organization providing international product development services in the pharmaceutical/biotech, life science and health care industries. In addition to its head office in Zurich, Switzerland, further international affiliates include Germany, Israel and India.

"I am very pleased that we can extend our clinical research services with DATATRAK to offer our clients access to a state of the art eClinical solution," said Ran Frenkel, VP Business Development of PFC Pharma Focus Ltd. "Selection of DATATRAK as a partner was a result of rigorous due diligence and a shared vision to provide cost effective technology solutions with the highest levels of credibility and flexibility."

"I am very happy to welcome PFC Pharma Focus to the growing list of DATATRAK CRO Partners," said Laurence Birch, DATATRAK's Chairman of the Board. "As more and more life science companies are turning to CROs to design, manage and conduct their drug programs, DATATRAK continues to expand its list of international CRO Connect Partners. Adopting DATATRAK eClinical(TM) enables both CROs and Sponsors to achieve greater efficiency and visibility in managing their clinical data."

About PFC.

Based in Switzerland, PFC Pharma Focus is a premium contract research organization (CRO), providing product development services in the life science and health care industries. Founded in 1992 by
'/>"/>

SOURCE DATATRAK International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015  IRIDEX Corporation (NASDAQ: IRIX ... and full year 2014 financial results after the market closes ... the release, the Company will host a conference call with ... Thursday, March 5, 2015 to discuss the ... Interested parties may access the live conference call via telephone ...
(Date:2/26/2015)... , Feb. 26, 2015  Mail-service and ... consumers, employers and government health plans $23.3 ... released by the Pharmaceutical Care Management Association (PCMA). ... drugs offers one of the easiest ways to ... Mark Merritt . "Policymakers should resist efforts ...
(Date:2/26/2015)... -- Every year many millions of donations are obtained ... year after year doctors and the medical profession continue ... to determine the status of heart health in all ... though that technology is over 100 years old, ... (while most patients do not know) that EKG,s, in ...
Breaking Medicine Technology:IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2National Heart Health Month In February 2
... as Marker of,Treatment Success -, SAN FRANCISCO, ... presented at the 59th Annual Meeting of,the American ... shows that,PEGASYS(R) (peginterferon alfa-2a) treatment regimens result in ... patients as,compared to regimens with another pegylated interferon.(1), ...
... Denmark, October 31 , - DoctorConsult in ... Improve Clinician Decision Making and Health Care Business,Performance, ... and more than a,century of experience as a ... provide interactive clinical reference and clinical decision,support (CDS) ...
Cached Medicine Technology:New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 2New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 3New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 4New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 5New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 6New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 7Elsevier is Expanding eClinical Solutions in Europe 2Elsevier is Expanding eClinical Solutions in Europe 3
(Date:2/27/2015)... Laguna Hills, CA (PRWEB) February 27, 2015 ... has been chosen as their Sage ERP Document Management ... ERP, Sage 300 ERP, Sage CRM and other complimentary ... ADSS Global have worked side-by-side for many years to ... their Sage ERP applications. , “We are thrilled ...
(Date:2/27/2015)... In New York City, a Brooklyn dentist is ... care from his Sheepshead Bay­neighborhood practice. Dr. Leonard ... Heart, and will be hosting a charity event on ... are in need of fillings, extractions, or professional dental ... high­quality service of Dr. Umanoff's practice on the Dentistry ...
(Date:2/27/2015)... February 27, 2015 The federal court ... that allege use of the statin medication can increase ... issued a new order pertaining discovery in the cases ... Liebhard LLP comments. The Order, which was issued in ... February 25th, directs the parties to schedule certain witness ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 According to ... General Hospital on June 25, 2013 and underwent a ... stomach through her mouth. Because the duodenoscope allegedly ... with the antibiotic-resistant “superbug” carbapenem-resistant Enterobacteriaceae (CRE). ... Court of Cook County on behalf of Ms. Pirolli ...
(Date:2/27/2015)... 2015 Adding to its rich ... Benedict Advertising & Marketing has added Sedation Systems ... company’s patented NITROUSEAL® N20 closed mask and breathing ... sedation. , Sedation Systems, http://www.sedationsystems.com is ... new level, though it focuses primarily on pediatric ...
Breaking Medicine News(10 mins):Health News:Altec Announces 2014 Sage ERP Document Management Partner of the Year Award Recipient 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 3Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2
... (CCC) have selected Turning The Tide Together as the theme ... be held in Washington, D.C. from 22 27 July ... moment in time, emphasizing that the AIDS epidemic has reached ... in HIV treatment and biomedical prevention, the momentum for a ...
... TUESDAY, Sept. 20 (HealthDay News) -- People affected by ... without it to develop schizophrenia, and those with schizophrenia ... than people who are not schizophrenic, a new study ... between the two conditions may be due to genetic, ...
... Mitchell, IGB faculty member in the Mining Microbial Genomes ... the Department of Chemistry, is a recipient of the ... The award recognizes bold ideas from some of the ... award, given over a period of five years, supports ...
... about cancer and cancer treatments can feel like learning a ... to understand their treatment options, and the risks and benefits ... death decisions that may affect their survival and they need ... tests can be serious. Patients need to know what kind ...
... An analysis of more than 30,000 cancer patients has ... doctors may realize, causing additional hospitalizations and driving up the ... Duke Cancer Institute researcher. The study, which will be ... in Stockholm, found that as many as one in five ...
... method of family planning developed by researchers from the ... effectively meets the needs of users that they continue to ... that women who follow the Standard Days Method, are likely ... Results of the large, multi-country study of 1659 women appear ...
Cached Medicine News:Health News:Turning the Tide Together: AIDS 2012 theme selected 2Health News:Researchers Find Link Between Epilepsy, Schizophrenia Risk 2Health News:10 ways to make better decisions about cancer care 2Health News:10 ways to make better decisions about cancer care 3Health News:Costly blood clots more common than expected among cancer patients 2Health News:Long-term effectiveness of new family planning method shown in study 2
1.7/2.2 mm Delta System resorbable implant technology merges science and simplicity for a superior craniomaxillofacial surgery product. The system consists of resorbable bone plates and screws fabric...
... A-scan Sonomed-315 is intended for visualization of ... of midline shifts in the brain, evaluation ... easy to use, the Sonomed-315 offers quick ... mode allows to identify the anatomic structures ...
... a scaleable device that works ... platelet plasma or buffy coat. ... coat must be prepared independently ... Starting volume and concentration factor ...
The Ultrafoam Collagen Sponge is indicated in all surgical procedures as an adjunct to hemostasis when control by ligature or conventional procedures are ineffective or impractical....
Medicine Products: